{"id":61133,"date":"2023-12-04T15:59:34","date_gmt":"2023-12-04T13:59:34","guid":{"rendered":"https:\/\/www.iemn.fr\/?p=61133"},"modified":"2023-12-15T15:05:47","modified_gmt":"2023-12-15T13:05:47","slug":"decouvrez-zymoptiq-revolution-dans-le-dosage-enzymatique","status":"publish","type":"post","link":"https:\/\/www.iemn.fr\/en\/newsletter\/decouvrez-zymoptiq-revolution-dans-le-dosage-enzymatique.html","title":{"rendered":"D\u00e9couvrez Zymoptiq : R\u00e9volution dans le dosage enzymatique"},"content":{"rendered":"<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-lpqyzli8-844f4a6ed83264ca7c3c59aa875aacd4\">\n.avia-image-container.av-lpqyzli8-844f4a6ed83264ca7c3c59aa875aacd4 img.avia_image{\nbox-shadow:none;\n}\n.avia-image-container.av-lpqyzli8-844f4a6ed83264ca7c3c59aa875aacd4 .av-image-caption-overlay-center{\ncolor:#ffffff;\n}\n<\/style>\n<div  class='avia-image-container av-lpqyzli8-844f4a6ed83264ca7c3c59aa875aacd4 av-styling-no-styling av-hover-grow avia_animated_image av-animated-when-visible-95 top-to-bottom avia-align-center  avia-builder-el-0  el_before_av_textblock  avia-builder-el-first'   itemprop=\"image\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/ImageObject\" ><div class=\"avia-image-container-inner\"><div class=\"avia-image-overlay-wrap\"><img decoding=\"async\" fetchpriority=\"high\" class='wp-image-61134 avia-img-lazy-loading-not-61134 avia_image' src=\"https:\/\/www.iemn.fr\/wp-content\/uploads\/2023\/12\/zymoptiq-845x321.png\" alt='' title='zymoptiq'  height=\"321\" width=\"845\"  itemprop=\"thumbnailUrl\"  \/><\/div><\/div><\/div>\n<section  class='av_textblock_section av-lpqzmcs4-12e11876ec32de7cac002d29028783ac'   itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock'  itemprop=\"text\" ><h1><strong><span style=\"color: #185078;\">D\u00e9couvrez Zymoptiq : R\u00e9volution dans le dosage enzymatique<\/span> <\/strong><\/h1>\n<\/div><\/section>\n<div  class='hr av-22188od-266b7e9829a92d9230e29566932ddea5 hr-default  avia-builder-el-2  el_after_av_textblock  el_before_av_one_half'><span class='hr-inner'><span class=\"hr-inner-style\"><\/span><\/span><\/div>\n\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-1nzinfx-7a18a5f52517282dfb6b54445d7fc968\">\n.flex_column.av-1nzinfx-7a18a5f52517282dfb6b54445d7fc968{\nborder-radius:0px 0px 0px 0px;\npadding:0px 0px 0px 0px;\n}\n<\/style>\n<div  class='flex_column av-1nzinfx-7a18a5f52517282dfb6b54445d7fc968 av_one_half  avia-builder-el-3  el_after_av_hr  el_before_av_one_half  first flex_column_div av-zero-column-padding'     ><style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-lpqz50i9-eb2150545a087a1ca2f48c4a70842471\">\n#top .av_textblock_section.av-lpqz50i9-eb2150545a087a1ca2f48c4a70842471 .avia_textblock{\nfont-size:15px;\n}\n<\/style>\n<section  class='av_textblock_section av-lpqz50i9-eb2150545a087a1ca2f48c4a70842471'   itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock'  itemprop=\"text\" ><blockquote>\n<p>Spin-off du CNRS, Zymoptiq propose une solution innovante de dosage enzymatique bas\u00e9e sur 2 brevets. Cofond\u00e9e par Alexis Vlandas, chercheur au CNRS, et Philippe Pebay, Zymoptiq s\u2019adresse aux industriels utilisateurs d\u2019enzymes. La vision de Zymoptiq repose sur l\u2019innovation constante, pour r\u00e9pondre aux applications enzymatiques des industriels, quel que soit le secteur.<\/p>\n<\/blockquote>\n<p>Parcourez <a href=\"https:\/\/zymoptiq.com\/\" target=\"_blank\" rel=\"noopener\"><strong><span style=\"color: #185078;\">leur site<\/span><\/strong><\/a> pour d\u00e9couvrir comment Zymoptiq marie expertise scientifique et vision novatrice pour implanter une nouvelle m\u00e9thode de dosage enzymatique. H\u00e9berg\u00e9e dans les locaux de l\u2019IEMN pendant un peu plus de 3 ans, l\u2019entreprise a r\u00e9cemment emm\u00e9nag\u00e9 dans de nouveaux bureaux, marquant ainsi une \u00e9tape cruciale dans son parcours.<\/p>\n<p>L\u2019\u00e9volution d\u2019une startup est parsem\u00e9e de jalons significatifs, et l\u2019un des moments charni\u00e8res est sans aucun doute le d\u00e9m\u00e9nagement vers ses propres locaux. Cela repr\u00e9sente bien plus qu\u2019un simple changement d\u2019adresse ; c\u2019est une \u00e9tape cruciale dans la croissance et la maturation de l\u2019entreprise.<\/p>\n<\/div><\/section><\/div>\n\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-124hqvh-5ee59ba86f781f5186cbb6ffa9aaef82\">\n.flex_column.av-124hqvh-5ee59ba86f781f5186cbb6ffa9aaef82{\nborder-radius:0px 0px 0px 0px;\npadding:0px 0px 0px 0px;\n}\n<\/style>\n<div  class='flex_column av-124hqvh-5ee59ba86f781f5186cbb6ffa9aaef82 av_one_half  avia-builder-el-5  el_after_av_one_half  el_before_av_one_full  flex_column_div av-zero-column-padding'     ><style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-lpqz5ftt-9118e8efcbbde957fd44bbe47dc1807d\">\n#top .av_textblock_section.av-lpqz5ftt-9118e8efcbbde957fd44bbe47dc1807d .avia_textblock{\nfont-size:15px;\n}\n<\/style>\n<section  class='av_textblock_section av-lpqz5ftt-9118e8efcbbde957fd44bbe47dc1807d'   itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock'  itemprop=\"text\" ><p>Zymoptiq a gard\u00e9 des liens forts avec l\u2019IEMN, puisqu\u2019elle y conserve une partie de ses bureaux et utilise les plateformes technologiques pour la production de ses capteurs en salle blanche. L\u2019installation dans ces nouveaux locaux a \u00e9t\u00e9, en effet, bien plus qu\u2019un simple d\u00e9m\u00e9nagement. Elle a renforc\u00e9 la coh\u00e9sion d\u2019une \u00e9quipe d\u00e9j\u00e0 passionn\u00e9e, offrant un espace d\u00e9di\u00e9 propice \u00e0 l\u2019innovation et \u00e0 la cr\u00e9ativit\u00e9.<\/p>\n<p>Cette expansion a \u00e9t\u00e9 marqu\u00e9e par le lancement r\u00e9ussi du capteur Xylanase VLA (<em>Very Low Activity<\/em>, Tr\u00e8s Basse Activit\u00e9) en novembre 2023. Le Xylanase VLA offre aux industriels du Feed une m\u00e9thode simplifi\u00e9e, plus rapide et plus efficace pour \u00e9valuer le taux de <em>Recovery Rate<\/em>. Ce dernier, crucial dans l\u2019industrie du Feed, garantit la quantit\u00e9 r\u00e9elle de Xylanase apr\u00e8s le proc\u00e9d\u00e9 de granulation. Ce proc\u00e9d\u00e9, bien qu\u2019essentiel dans la pr\u00e9paration des rations alimentaires pour le b\u00e9tail, peut endommager les enzymes incorpor\u00e9s. Ces enzymes jouent un r\u00f4le crucial dans l\u2019augmentation de la digestibilit\u00e9 des ingr\u00e9dients, soulignant ainsi l\u2019importance vitale du contr\u00f4le du <em>Recovery Rate<\/em>.<\/p>\n<p><span style=\"color: #185078;\">Zymoptiq incarne l\u2019essence de l\u2019innovation, combinant expertise scientifique et connaissance industrielle pour r\u00e9soudre des d\u00e9fis critiques de l\u2019industrie. Restez \u00e0 l\u2019aff\u00fbt des prochaines avanc\u00e9es de Zymoptiq, alors qu\u2019ils continuent de red\u00e9finir les normes de dosage enzymatique.<\/span><\/p>\n<\/div><\/section><\/div>\n\n<style type=\"text\/css\" data-created_by=\"avia_inline_auto\" id=\"style-css-av-j1ly99-9df751d842b160c386b519eacd721d08\">\n.flex_column.av-j1ly99-9df751d842b160c386b519eacd721d08{\nborder-radius:0px 0px 0px 0px;\npadding:0px 0px 0px 0px;\n}\n<\/style>\n<div  class='flex_column av-j1ly99-9df751d842b160c386b519eacd721d08 av_one_full  avia-builder-el-7  el_after_av_one_half  el_before_av_slideshow_accordion  avia-builder-el-last  first flex_column_div av-zero-column-padding  column-top-margin'     ><section  class='av_textblock_section av-lpqzg1di-5e6289da09a8a80a4a6f134d54d0efa4'   itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock'  itemprop=\"text\" ><p><a href=\"https:\/\/www.iemn.fr\/wp-content\/uploads\/2023\/12\/zymoptiq-article-1.png\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-61146\" src=\"https:\/\/www.iemn.fr\/wp-content\/uploads\/2023\/12\/zymoptiq-article-1.png\" alt=\"\" width=\"404\" height=\"297\" srcset=\"https:\/\/www.iemn.fr\/wp-content\/uploads\/2023\/12\/zymoptiq-article-1.png 404w, https:\/\/www.iemn.fr\/wp-content\/uploads\/2023\/12\/zymoptiq-article-1-300x221.png 300w, https:\/\/www.iemn.fr\/wp-content\/uploads\/2023\/12\/zymoptiq-article-1-16x12.png 16w\" sizes=\"auto, (max-width: 404px) 100vw, 404px\" \/><\/a><\/p>\n<\/div><\/section><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":20,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[297],"tags":[],"class_list":["post-61133","post","type-post","status-publish","format-standard","hentry","category-newsletter"],"_links":{"self":[{"href":"https:\/\/www.iemn.fr\/en\/wp-json\/wp\/v2\/posts\/61133","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.iemn.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.iemn.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.iemn.fr\/en\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/www.iemn.fr\/en\/wp-json\/wp\/v2\/comments?post=61133"}],"version-history":[{"count":0,"href":"https:\/\/www.iemn.fr\/en\/wp-json\/wp\/v2\/posts\/61133\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.iemn.fr\/en\/wp-json\/wp\/v2\/media?parent=61133"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.iemn.fr\/en\/wp-json\/wp\/v2\/categories?post=61133"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.iemn.fr\/en\/wp-json\/wp\/v2\/tags?post=61133"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}